Literature DB >> 19226394

How much ozone bactericidal activity is compromised by plasma components?

S Burgassi1, I Zanardi, V Travagli, E Montomoli, V Bocci.   

Abstract

AIMS: Evaluation of bactericidal effect of different concentrations of ozone when used (a) as a gas, or (b) dissolved in saline. The addition of hydrogen peroxide or 4-hydroxynonenal dissolved in saline was also tested, as well as the effect of human plasma. METHODS AND
RESULTS: Staphylococcus aureus, methicillin-resistant Staph. aureus (MRSA), and Pseudomonas aeruginosa, suspended in their culture media were tested. While all bacteria suspended in protein-free saline were killed at high ozone concentrations, they survived when as little as 5% human plasma was present. Hydrogen peroxide was 100-fold less active than ozone and needed to remain in contact with bacteria for at least 60 min. 4-hydroxynonenal (2 micromol l(-1)) was inhibitory for proliferation of both Staph. aureus and MRSA, but not for Ps. aeruginosa.
CONCLUSIONS: Ozone and the cascade of its derivative products are potent bactericidal agents, but even small amounts of human plasma, hence of hydro- and liposoluble antioxidants, in bacterial suspensions inhibit oxidation and protect bacteria. SIGNIFICANCE AND IMPACT OF THE STUDY: Any substantial in vivo cytocidal effect of ozone and its derivatives can be excluded. On the other hand, topical and continuous action of various ozone preparations remains valuable in a variety of skin and mucosal infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226394     DOI: 10.1111/j.1365-2672.2008.04141.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  11 in total

1.  Effect of ozone on periodontopathogenic species--an in vitro study.

Authors:  Sigrun Eick; Marius Tigan; Anton Sculean
Journal:  Clin Oral Investig       Date:  2011-02-02       Impact factor: 3.573

2.  Microbicidal Effects of Stored Aqueous Ozone Solution Generated by Nano-bubble Technology.

Authors:  Mineaki Seki; Tatsuya Ishikawa; Hiroshi Terada; Masayuki Nashimoto
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

3.  Ozone acting on human blood yields a hormetic dose-response relationship.

Authors:  Velio A Bocci; Iacopo Zanardi; Valter Travagli
Journal:  J Transl Med       Date:  2011-05-17       Impact factor: 5.531

4.  Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?

Authors:  Masaru Sagai; Velio Bocci
Journal:  Med Gas Res       Date:  2011-12-20

5.  Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects.

Authors:  Velio Bocci; Iacopo Zanardi; Valter Travagli
Journal:  Med Gas Res       Date:  2011-04-28

Review 6.  Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.

Authors:  Gregorio Martínez-Sánchez; Adriana Schwartz; Vincenzo Di Donna
Journal:  Antioxidants (Basel)       Date:  2020-05-06

7.  Antibacterial effect of ozonated water against methicillin-resistant Staphylococcus aureus contaminating chicken meat in Wasit Province, Iraq.

Authors:  Manal H G Kanaan
Journal:  Vet World       Date:  2018-10-18

8.  Antibacterial and safety tests of a flexible cold atmospheric plasma device for the stimulation of wound healing.

Authors:  Bouke Boekema; Matthea Stoop; Marcel Vlig; Jos van Liempt; Ana Sobota; Magda Ulrich; Esther Middelkoop
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

9.  Ozonation of Whole Blood Results in an Increased Release of Microparticles from Blood Cells.

Authors:  Barbara Boczkowska-Radziwon; Piotr Józef Olbromski; Anna Rogowska; Magdalena Bujno; Marta Myśliwiec; Agnieszka Żebrowska; Dariusz Średziński; Barbara Polityńska; Marek Z Wojtukiewicz; Piotr Radziwon
Journal:  Biomolecules       Date:  2022-01-21

10.  What is the best strategy for enhancing the effects of topically applied ozonated oils in cutaneous infections?

Authors:  I Zanardi; S Burgassi; E Paccagnini; M Gentile; V Bocci; V Travagli
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.